ClinicalTrials.gov
ClinicalTrials.gov Menu

Hospital vs. Cell Phone Number Follow-Up Randomization Study (FURS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01620827
Recruitment Status : Completed
First Posted : June 15, 2012
Last Update Posted : August 19, 2016
Sponsor:
Information provided by (Responsible Party):
University of Pennsylvania

Brief Summary:
This study is being conducted to evaluate the hypothesis that study subjects will be more responsive to follow-up phone calls made from personal cell phone numbers than from hospital landline numbers. To evaluate this, study subjects previously enrolled in a cardiac biomarker study (the Early Identification of Acute Coronary Syndrome study) were randomized to receive their follow-up phone calls (the calls associated with the Early ID study occur at 30 days and 1 year after initial enrollment) from either a hospital office landline or from the personal cell phones of the research assistants making these calls. This was done as a 1:1 randomization. The number of call attempts required to reach the study subjects were recorded as the calls were made and the date of successful follow-up was recorded once contact was made.

Condition or disease Intervention/treatment Phase
Subject Follow-up Other: Hospital Landline Phone Calls Other: Private Cell Phone Calls Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 400 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Study Subject Responsiveness to Follow-Up Phone Calls From a Hospital Landline as Compared With From a Private Cellular Phone Number
Study Start Date : February 2012
Actual Primary Completion Date : July 2013
Actual Study Completion Date : July 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: Hospital Landline
Subjects in this arm have all of their follow-up phone calls placed from a hospital landline number.
Other: Hospital Landline Phone Calls
Follow-up phone calls are made from the hospital landline phones in a research office
Active Comparator: Private Cell Phone
Subjects in this arm have all of their follow-up phone calls placed from a private cell phone number.
Other: Private Cell Phone Calls
Follow-up phone calls are made from the private cell phones of research assistants



Primary Outcome Measures :
  1. Successful phone call contact at 30 days [ Time Frame: 90 days ]
    Contact is attempted from 30 days after enrollment through 90 days after enrollment. If contact is made during this time frame, 30 day follow-up is considered to have been successful.


Secondary Outcome Measures :
  1. The number of call attempts required to obtain successful follow-up [ Time Frame: 90 days ]
    Contact is attempted from 30 days after enrollment through 90 days after enrollment. The number of calls required to make successful contact in this time frame are recorded.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Enrollment in the Early Identification of Acute Coronary Syndrome study
  • Working telephone numbers

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01620827


Locations
United States, Pennsylvania
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
University of Pennsylvania
Investigators
Principal Investigator: Judd Hollander, MD University of Pennsylvania

Responsible Party: University of Pennsylvania
ClinicalTrials.gov Identifier: NCT01620827     History of Changes
Other Study ID Numbers: HUP-FURS-2012
First Posted: June 15, 2012    Key Record Dates
Last Update Posted: August 19, 2016
Last Verified: August 2016

Keywords provided by University of Pennsylvania:
follow up
cell phone
hospital landline